The impacts of SARS-CoV-2 vaccine dose separation and targeting on the COVID-19 epidemic in England

Abstract

In England, SARS-CoV-2 vaccines were initially targeted to older, more vulnerable people; first vaccine doses were prioritised over second doses, and an interval of twelve weeks was used between doses. Here, the authors assess the impacts of these policy decisions by simulating counterfactual scenarios.